Abstract
Multi-drug resistant pathogens have been of increasing concern today. There is an urgent need for the discovery of more potent antibiotics. Cationic antimicrobial peptides (CAMPs) are known to be effective antimicrobial agents against resistant pathogens. However, poor activity under physiological conditions is one of the major limitations of CAMPS in clinical applications. In this study, a series of oligo-lipidated arginyl peptide OLAP dimers comprised of a saturated fatty acid chain (with m number of carbon units) and p repeating units of arginyl fatty acid chains (with n number of carbon units) were designed and studied for their antimicrobial activities as well as their physico-chemical property in various physiological conditions, such as in human serum albumin and high salt conditions. Our results showed that OLAP-11 exhibits potent antimicrobial activity against Gram-positive bacteria with improved physico-chemical activity in various physiological conditions. OLAP-11 is also less susceptible to human serum and trypsin degradation. The HPLC–MS analysis showed that the lipid-arginine bond is very stable. SYTOX Green assay and scanning electron microscopy both show that the OLAP-11 killed bacteria via inner membrane disruption. In addition, OLAP-11 is inner membrane targeting, making it difficult for bacteria to develop resistance. Overall, the design of the OLAP dimers provides an alternative approach to improve the physicochemical activity, peptide stability of CAMPs with potent inner membrane disruption and low in vitro toxicity to increase their potential for clinical applications in the future.
Similar content being viewed by others
Abbreviations
- OLAP:
-
Oligo-lipidated arginyl peptide
- CAMP:
-
Cationic antimicrobial peptide
- HSA:
-
Human serum albumin
- MIC:
-
Minimum inhibitory concentration
- MRSA:
-
Methicillin-resistant Staphylococcus aureus
- DOPE:
-
1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine
- DOPG:
-
1,2-Dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol)
- CL:
-
Cardiolipin
- OAK:
-
Oligo-acyl-lysine OAK
- CAMHB:
-
Cationic-adjusted Mueller–Hinton broth
- CFU:
-
Colony forming units
- RBC:
-
Red blood cells
- ANSA:
-
8-(Phenylamino)-1-naphtha-lenesulfonic acid
- MDR:
-
Multi-drug resistant
- AMP:
-
Antimicrobial peptide
- HPLC–MS:
-
High-performance liquid chromatography-mass spectrometry
- OAK:
-
Oligo-acyl-lysine
- CLSI:
-
Clinical and Laboratory Standards Institute
- TSA:
-
Trypticase soy agar
- MHA:
-
Mueller–Hinton agar
- HEPES:
-
(4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid)
- LUV:
-
Large unilamellar vehicle
References
Alanis AJ (2005) Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res 36(6):697–705
Ascenzi P, Gioia M, Fanali G, Coletta M, Fasano M (2012) Pseudo-enzymatic hydrolysis of 4-nitrophenyl acetate by human serum albumin: pH-dependence of rates of individual steps. Biochem Biophys Res Commun 424:451–455
Bahar AA, Ren D (2013) Antimicrobial peptides. Pharmaceuticals (Basel) 6:1543–1575
Balsalobre LC, Dropa M, Matte MH (2014) An overview of antimicrobial resistance and its public health significance. Braz J Microbiol 45:1–5
Bottcher T, Kolodkin-Gal I, Kolter R, Losick R, Clardy J (2013) Synthesis and activity of biomimetic biofilm disruptors. J Am Chem Soc 135:2927–2930
Bourassa P, Kanakis CD, Tarantilis P, Pollissiou MG, Tajmir-Riahi HA (2010) Resveratrol, genistein, and curcumin bind bovine serum albumin. J Phys Chem B 114:3348–3354
Chopra I, Hesse L, O’Neill AJ (2002) Exploiting current understanding of antibiotic action for discovery of new drugs. Symp Ser Soc Appl Microbiol 92:4S–15S
Citterio L, Franzyk H, Palarasah Y, Andersen TE, Mateiu RV, Gram L (2016) Improved in vitro evaluation of novel antimicrobials: potential synergy between human plasma and antibacterial peptidomimetics, AMPs and antibiotics against human pathogenic bacteria. Res Microbiol 167:72–82
Coates AR, Hu Y (2008) Targeting non-multiplying organisms as a way to develop novel antimicrobials. Trends Pharmacol Sci 29:143–150
Dalbey RE, Wang P, Kuhn A (2011) Assembly of bacterial inner membrane proteins. Annu Rev Biochem 80:161–187
Delcour AH (2009) Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 1794:808–816
Dubeau S, Bourassa P, Thomas TJ, Tajmir-Riahi HA (2010) Biogenic and synthetic polyamines bind bovine serum albumin. Biomacromolecules 11:1507–1515
Epand RM, Epand RF (2011) Bacterial membrane lipids in the action of antimicrobial agents. J Pept Sci 17:298–305
Friguet B, Szweda LI, Stadtman ER (1994) Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch Biochem Biophys 311:168–173
Gentilucci L, De Marco R, Cerisoli L (2010) Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr Pharm Des 16:3185–3203
Giuliani A, Rinaldi AC (2011) Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches. Cell Mol Life Sci 68:2255–2266
Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM (1997) Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553–560
Hancock RE, Lehrer R (1998) Cationic peptides: a new source of antibiotics. Trends Biotechnol 16:82–88
Jenssen H, Hamill P, Hancock RE (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19:491–511
John H, Maronde E, Forssmann WG, Meyer M, Adermann K (2008) N-terminal acetylation protects glucagon-like peptide GLP-1-(7-34)-amide from DPP-IV-mediated degradation retaining cAMP- and insulin-releasing capacity. Eur J Med Res 13:73–78
Koh JJ, Lin H, Caroline V, Chew YS, Pang LM, Aung TT, Li J, Lakshminarayanan R, Tan DT, Verma C, Tan AL, Beuerman RW, Liu S (2015) N-lipidated peptide dimers: effective antibacterial agents against Gram-negative pathogens through lipopolysaccharide permeabilization. J Med Chem 58:6533–6548
Koh JJ, Lin S, Beuerman RW, Liu S (2017) Recent advances in synthetic lipopeptides as anti-microbial agents: designs and synthetic approaches. Amino Acids 49:1653–1677
Kosowska-Shick K, Clark C, Pankuch GA, McGhee P, Dewasse B, Beachel L, Appelbaum PC (2009) Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies. Antimicrob Agents Chemother 53:4217–4224
Levin BR, Rozen DE (2006) Non-inherited antibiotic resistance. Nat Rev Microbiol 4:556–562
Li J, Liu S, Koh JJ, Zou H, Lakshminarayanan R, Bai Y, Pervushin K, Zhou L, Verma C, Beuerman RW (2015) A novel fragment based strategy for membrane active antimicrobials against MRSA. Biochim Biophys Acta 1848:1023–1031
Li J, Koh JJ, Liu S, Lakshminarayanan R, Verma CS, Beuerman RW (2017) Membrane active antimicrobial peptides: translating mechanistic insights to design. Front Neurosci 11:73
McDuff FO, Doucet A, Beauregard M (2004) Low concentration of guanidine hydrochloride induces the formation of an aggregation-prone state in alpha-urease. Biochem Cell Biol 82:305–313
Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6:29–40
Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, Musser JM (2014) Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect 69:216–225
Radzishevsky IS, Rotem S, Bourdetsky D, Navon-Venezia S, Carmeli Y, Mor A (2007) Improved antimicrobial peptides based on acyl-lysine oligomers. Nat Biotechnol 25:657–659
Radzishevsky IS, Kovachi T, Porat Y, Ziserman L, Zaknoon F, Danino D, Mor A (2008) Structure-activity relationships of antibacterial acyl-lysine oligomers. Chem Biol 15:354–362
Roth BL, Poot M, Yue ST, Millard PJ (1997) Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain. Appl Environ Microbiol 63:2421–2431
Schmidtchen A, Pasupuleti M, Malmsten M (2014) Effect of hydrophobic modifications in antimicrobial peptides. Adv Colloid Interface Sci 205:265–274
Scott RW, DeGrado WF, Tew GN (2008) De novo designed synthetic mimics of antimicrobial peptides. Curr Opin Biotechnol 19:620–627
Shen H, Gu Z, Jian K, Qi J (2013) In vitro study on the binding of gemcitabine to bovine serum albumin. J Pharm Biomed Anal 75:86–93
Shin SY, Yang ST, Park EJ, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI (2002) Salt resistance and synergistic effect with vancomycin of alpha-helical antimicrobial peptide P18. Biochem Biophys Res Commun 290:558–562
Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48:4673–4679
Srinivas N, Jetter P, Ueberbacher BJ, Werneburg M, Zerbe K, Steinmann J, Van der Meijden B, Bernardini F, Lederer A, Dias RL, Misson PE, Henze H, Zumbrunn J, Gombert FO, Obrecht D, Hunziker P, Schauer S, Ziegler U, Kach A, Eberl L, Riedel K, DeMarco SJ, Robinson JA (2010) Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 327:1010–1013
Stromstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M (2009) Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother 53:593–602
Verkleij AJ, Zwaal RF, Roelofsen B, Comfurius P, Kastelijn D, van Deenen LL (1973) The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim Biophys Acta 323:178–193
Wang Y, Rezk AR, Khara JS, Yeo LY, Ee PL (2016a) Stability and efficacy of synthetic cationic antimicrobial peptides nebulized using high frequency acoustic waves. Biomicrofluidics 10:034115
Wang B, Pachaiyappan B, Gruber JD, Schmidt MG, Zhang YM, Woster PM (2016b) Antibacterial diamines targeting bacterial membranes. J Med Chem 59:3140–3151
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389–395
Zhou L, Liu SP, Chen LY, Li J, Ong LB, Guo L, Wohland T, Tang CC, Lakshminarayanan R, Mavinahalli J, Verma C, Beuerman RW (2011) The structural parameters for antimicrobial activity, human epithelial cell cytotoxicity and killing mechanism of synthetic monomer and dimer analogues derived from hBD3 C-terminal region. Amino Acids 40:123–133
Acknowledgements
This work was supported by the National Medical Research Council NMRC/CBRG/0080/2015 and NMRC/TCR/R1012. This work is also supported by the Singhealth Foundation SHF/FG691S/2016.
Author information
Authors and Affiliations
Contributions
The manuscript was written with contributions from all the authors. All the authors approved the final version of the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human participants
This article does not contain any studies with human participants performed by any of the authors.
Ethical standards
All procedures performed in studies involving animals were in accordance with the ethical standards of the SingHealth IACUC in accordance with the guidelines of the Association for Research in Vision and Ophthalmology (ARVO) at which the studies were conducted.
Additional information
Handling Editor: J. D. Wade.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Koh, JJ., Lin, S., Sin, W.W.L. et al. Design and synthesis of oligo-lipidated arginyl peptide (OLAP) dimers with enhanced physicochemical activity, peptide stability and their antimicrobial actions against MRSA infections. Amino Acids 50, 1329–1345 (2018). https://doi.org/10.1007/s00726-018-2607-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-018-2607-6